What is the recommended dose of losartan (angiotensin II receptor antagonist) for adults with hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage of Losartan for Adults with Hypertension

The recommended starting dose of losartan for adults with hypertension is 50 mg once daily, with titration to a maximum dose of 100 mg once daily as needed to control blood pressure. 1

Initial Dosing Considerations

  • For most adults with hypertension, start with 50 mg once daily
  • For patients with possible intravascular depletion (e.g., those on diuretic therapy), a lower starting dose of 25 mg is recommended 1
  • Losartan can be administered without regard to food 2
  • For patients with mild-to-moderate hepatic impairment, the recommended starting dose is 25 mg once daily 1

Dose Titration

  • Blood pressure should be monitored 2-4 weeks after initiation or dose adjustment 3
  • If blood pressure control is not achieved with the initial 50 mg dose, increase to the maximum dose of 100 mg once daily 1
  • For stage 2 hypertension (BP ≥160/100 mmHg), combination therapy with two antihypertensive agents of different classes should be considered 4

Special Populations

Patients with Diabetic Nephropathy

  • Start with 50 mg once daily
  • Increase to 100 mg once daily based on blood pressure response 1
  • Studies show that 100 mg daily is more effective than 50 mg daily for renoprotection and blood pressure reduction in diabetic nephropathy 5

Patients with Left Ventricular Hypertrophy

  • Start with 50 mg once daily
  • Consider adding hydrochlorothiazide 12.5 mg daily and/or increasing losartan to 100 mg once daily based on blood pressure response 1

Patients with Heart Failure

  • Target dose is 100 mg once daily
  • A minimum of at least 50% of the target dose (50 mg daily) is recommended for clinical benefit 4
  • Therapies must be titrated to maximally tolerated doses in patients with heart failure with reduced ejection fraction 4

Efficacy and Safety

  • Losartan doses of 50-100 mg once daily provide statistically significant systolic/diastolic mean decreases in blood pressure compared to placebo 1
  • The 100 mg dose has been shown to be more effective than 50 mg in reducing albuminuria and blood pressure in patients with diabetic nephropathy 5
  • Losartan is generally well-tolerated with minimal serious adverse events 3
  • The most common side effect is dizziness, which occurs at a similar rate to placebo 6

Monitoring Recommendations

  • Check blood pressure 2-4 weeks after initiation or dose adjustment 3
  • Monitor serum creatinine, estimated glomerular filtration rate (eGFR), and potassium levels at baseline and at least annually 3
  • More frequent monitoring is recommended for patients with chronic kidney disease or those on medications affecting potassium levels 3

Important Precautions

  • Do not use losartan in combination with ACE inhibitors or direct renin inhibitors due to increased risk of adverse effects 4
  • Avoid use during pregnancy, particularly in the second and third trimesters, due to risk of fetal toxicity 2
  • Losartan has not been studied in patients with severe hepatic impairment 1

By following these dosing recommendations and monitoring parameters, losartan can effectively control blood pressure in adults with hypertension while minimizing potential adverse effects.

References

Research

Clinical pharmacokinetics of losartan.

Clinical pharmacokinetics, 2005

Guideline

Losartan Therapy for Diabetic Nephropathy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Optimal dose of losartan for renoprotection in diabetic nephropathy.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.